SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-072644
Filing Date
2023-12-22
Accepted
2023-12-22 16:15:04
Documents
4
Period of Report
2023-12-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A apvo-2023-def_14a_-_rev.htm DEF 14A 1193538
2 GRAPHIC img185529953_0.jpg GRAPHIC 156384
3 GRAPHIC img185529953_1.jpg GRAPHIC 570330
4 GRAPHIC img185529953_2.jpg GRAPHIC 468118
  Complete submission text file 0000950170-23-072644.txt   2839372
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37746 | Film No.: 231509943
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)